Asset
BAVDEGALUTAMIDE
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05177042 | phase1 | completed | 2022-05-13 | 2024-07-02 | Arvinas Androgen Receptor, Inc. | Trial of ARV-110 and Abiraterone in Participants With Metastatic Prostate Cancer |
| NCT03888612 | phase1_2 | completed | 2019-03-01 | 2024-04-29 | Arvinas Inc. | Trial of ARV-110 in Patients With Metastatic Castration Resistant Prostate Cancer |
FDA applications (0)
This company has no applications containing this asset.